Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

20 results

The latest Legal Updates straight to your mailbox

We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates.

Digital Law Up(to)date: No processing of vaccination status in recruitment process

The Litigation Chamber of the Belgian DPA confirms that, in the absence of an existing legal basis, it is not possible for an employer, in this case a hospital, to make the recruitment of a person conditional on the fact that he/she has been vaccinated.

Het federale regeerakkoord door een publiekrechtelijke bril

De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan.

Stibbe advises Avista Capital Partners

Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.

Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures

The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.

Contracts & Corona: force majeure and related topics

The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions.

Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review

Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. 

 

Stibbe advises LDA Capital

Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.

Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe

Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.

Stibbe advises pharmaceutical multinational

Stibbe assisted a pharmaceutical multinational in complex litigations.

Stibbe advises KBC Securities

Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.

Stibbe advises worldwide seeds leader

Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.

Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective”

Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.

Stibbe advises DW Healthcare Partners

Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.

Stibbe advises leading pharmaceutical company

Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.

Stibbe advises client in the pharmaceutical sector

Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.

Stibbe advises leading plasma protein biotherapeutics company

Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.

Stibbe advises biotech company

Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.

Pagination

  • Current page 1
  • Page 2
  • Next page
Reset filters
Date
Content type
  • Article (7)
  • Event (1)
  • Matter (12)
Expertise
  • (-) Healthcare and Life Sciences (20)
  • Audit Firms and Accountancy (2)
  • Banking and Finance (52)
  • Capital Markets (35)
  • Compliance, Sanctions and Risk (16)
  • Corporate and M&A (117)
  • Corporate Investigations (3)
  • Criminal Law and Enforcement (25)
  • Digital Economy (6)
  • Employment, Benefits and Pensions (31)
  • Energy, Industry and Climate (49)
  • Environment and Planning (59)
  • ESG & Sustainability (9)
  • EU and Competition Law (60)
  • Financial Regulation (10)
  • Infrastructure and Mobility (43)
  • Insurance (8)
  • Intellectual Property (38)
  • Investment Funds (26)
  • Litigation and Arbitration (45)
  • Privacy and Data Protection (55)
  • Private Equity (26)
  • Procurement Law (32)
  • Public Law (86)
  • Real Estate (97)
  • Restructuring and Insolvency (12)
  • Sports (4)
  • Stibbe StartsUP (2)
  • Tax (56)
  • Technology, Media and Telecommunications (95)
  • Unfair Competition and Consumer Protection (26)
Jurisdiction
  • (-) BE Law (20)
  • EU Law (9)
  • LU Law (5)
  • NL Law (35)
Language
  • (-) English (20)
  • Dutch (1)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Cookies Settings
  • Important Information